GO:0008859 exoribonuclease II activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008859 (exoribonuclease II activity) describes the catalysis of RNA hydrolysis in the 3' to 5' direction, releasing 5'-phosphomononucleotides.
• The canonical enzyme, RNase II (encoded by rnb in Escherichia coli), is a processive 3'-5' exoribonuclease that degrades single-stranded RNA but stalls at double-stranded regions.
• RNase II is a key player in mRNA turnover and quality control, working together with other 3'-5' exoribonucleases such as RNase R and the degradosome.
• Its activity is regulated by post-translational modifications, including reversible acetylation on Lys501, which modulates catalytic efficiency.
• In some bacteria, RNase II physically interacts with endoribonuclease RNase E and modulates its activity, linking exo- and endonucleolytic pathways.
• Dysregulation of 3'-5' exoribonucleases is linked to bacterial pathogenicity and has attracted interest as a target for novel antibacterial inhibitors.
Description
Exoribonuclease II activity (GO:0008859) is a molecular function that catalyzes the removal of nucleotides from the 3' end of RNA molecules, generating 5'-phosphomononucleotides. This activity is essential for RNA processing, quality control, and degradation in bacteria and eukaryotes, and it is carried out by enzymes such as RNase II in Escherichia coli. The reaction proceeds processively in the 3' to 5' direction, and the enzyme is unable to cleave double-stranded RNA, which distinguishes it from other exoribonucleases like RNase R. Understanding this activity is fundamental for researchers studying RNA metabolism, because it directly influences mRNA half-life and the availability of coding and non-coding RNAs. The importance of exoribonuclease II activity extends beyond basic RNA biology. In bacteria, RNase II is a major contributor to global mRNA decay and works in concert with endoribonucleases and other exoribonucleases to maintain RNA homeostasis. Its activity is tightly regulated, for example by acetylation of a conserved lysine residue, which can alter its catalytic properties. Moreover, RNase II can interact with the endoribonuclease RNase E, suggesting a broader role in coordinating RNA processing events. These features make exoribonuclease II activity a compelling target for both mechanistic studies and applied research, including the development of new antibacterial agents. For researchers, GO:0008859 provides a precise functional annotation to interpret genomic and transcriptomic data. Whether investigating bacterial stress responses, RNA quality control, or host-pathogen interactions, the ability to measure and manipulate exoribonuclease II activity is crucial. This article summarizes the current understanding of the mechanism, key genes, and experimental approaches for studying this activity, with a focus on CRISPR-based models and modern RNA analysis techniques.
exoribonuclease II activity At A Glance
| GO ID | GO:0008859 |
|---|---|
| GO term | exoribonuclease II activity |
| Ontology | molecular_function |
| Synonym | RNase II; ribonuclease II activity; 5'-exoribonuclease activity; Escherichia coli exo-RNase II; ribonuclease Q; BN ribonuclease activity |
| Major function | Catalyzes the 3' to 5' exonucleolytic cleavage of RNA, releasing 5'-phosphomononucleotides |
| Directionality | 3' to 5' |
| Substrate | Single-stranded RNA |
| Product | 5'-phosphomononucleotides |
| Representative enzyme | RNase II (encoded by rnb in Escherichia coli) |
What Is GO:0008859?
Exoribonuclease II activity (GO:0008859) is defined as the catalysis of the reaction RNA + H2O = 5'-phosphomononucleotides, cleaving RNA in the 3' to 5' direction. In simpler terms, it is an enzyme activity that chews away RNA from its 3' end, one nucleotide at a time, releasing 5'-phosphate nucleotides. This activity is characteristic of the RNase II family of enzymes, which are processive exoribonucleases that degrade single-stranded RNA but are blocked by double-stranded structures.
Why Is exoribonuclease II activity Important in Cell Biology?
Exoribonuclease II activity is a cornerstone of RNA metabolism, directly controlling the stability and turnover of both coding and non-coding RNAs. In bacteria, it is one of the major 3'-5' exoribonucleases responsible for mRNA decay, and its activity influences gene expression at the post-transcriptional level. Because RNase II can interact with the endoribonuclease RNase E, it also participates in the coordination of endo- and exonucleolytic RNA processing. The enzyme's activity is subject to regulation by acetylation, linking metabolic states to RNA degradation capacity. From a biomedical perspective, exoribonuclease II activity is important for bacterial virulence and survival, making it a potential target for new antibiotics. Thus, understanding this activity is essential for researchers in microbiology, RNA biology, and drug discovery.
• Controls mRNA half-life and gene expression in bacteria.
• Participates in RNA quality control and degradation of non-coding RNAs.
• Interacts with RNase E to modulate endoribonucleolytic activity.
• Regulated by reversible acetylation on Lys501, affecting catalytic efficiency.
• Distinct from RNase R in its inability to degrade structured RNA, providing substrate specificity.
• Contributes to bacterial pathogenicity and is a target for antibacterial inhibitor development.
• Essential for understanding the prokaryotic counterparts of the eukaryotic exosome complex.
• Provides a functional annotation for interpreting transcriptomic and RNA-seq data.
• Plays a role in the metabolism of both coding and non-coding RNA.
• Offers a model system for studying processive exoribonuclease mechanisms.
Molecular Mechanism of exoribonuclease II activity
Substrate recognition and binding
In simple terms: The enzyme grabs the loose 3' end of an RNA molecule.
RNase II binds to the 3' end of single-stranded RNA. It requires a free 3'-hydroxyl group and cannot initiate degradation from a structured or double-stranded region. The enzyme's active site accommodates the RNA chain and positions it for cleavage. This binding step is essential for processive degradation, as the enzyme must maintain contact with the substrate while removing nucleotides.
Catalytic cleavage and product release
In simple terms: It cuts off one nucleotide at a time from the 3' end.
The catalytic mechanism involves a water molecule that attacks the phosphodiester bond, releasing a 5'-phosphomononucleotide and leaving a shortened RNA chain with a new 3'-hydroxyl end. This reaction is repeated processively, meaning the enzyme does not dissociate after each cleavage event. The products are 5'-phosphomononucleotides, as defined by GO:0008859.
Processivity and stalling at secondary structures
In simple terms: The enzyme keeps chewing until it hits a knot in the RNA.
RNase II is highly processive on unstructured RNA but stalls when it encounters double-stranded regions or strong secondary structures. This property distinguishes it from RNase R, which can degrade structured RNA. The stalling behavior is important for its biological role, as it allows partial degradation of RNAs and may generate intermediates for further processing by other enzymes.
Regulation by acetylation
In simple terms: A chemical tag on the enzyme can turn its activity up or down.
Reversible acetylation of lysine 501 (Lys501) in RNase II regulates its catalytic activity. Acetylation of this residue decreases the enzyme's ability to degrade RNA, while deacetylation restores activity. This post-translational modification provides a mechanism to rapidly adjust RNA decay rates in response to cellular signals.
Interaction with RNase E and the degradosome
In simple terms: It teams up with a partner enzyme to process RNA more efficiently.
In some bacteria, such as Anabaena PCC 7120, RNase II physically binds to the endoribonuclease RNase E and modulates its endoribonucleolytic activity. This interaction links exoribonuclease II activity to the larger RNA degradosome machinery, coordinating endonucleolytic cleavage with exonucleolytic trimming. Such partnerships are thought to enhance the efficiency and specificity of RNA processing.
Key Genes Involved in GO:0008859 exoribonuclease II activity
The following genes and proteins are central to exoribonuclease II activity and its regulation, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| rnb (E. coli) | Encodes RNase II, the primary enzyme with exoribonuclease II activity | Model for mechanistic and regulatory studies |
| rnr (E. coli) | Encodes RNase R, a related 3'-5' exoribonuclease that can degrade structured RNA | Comparative studies with RNase II |
| rne (Anabaena PCC 7120) | Encodes RNase E, an endoribonuclease that interacts with RNase II | Studying cross-talk between endo- and exonucleases |
| Lys501 (RNase II residue) | Site of reversible acetylation that regulates RNase II activity | Investigating post-translational regulation |
| pnp (E. coli) | Encodes polynucleotide phosphorylase, another 3'-5' exoribonuclease | Understanding redundant exoribonuclease functions |
| rnr (Mycobacterium tuberculosis) | RNase R homolog in a pathogen | Target for antibacterial development |
| rnb (Salmonella typhimurium) | RNase II homolog in a pathogen | Studying role in virulence |
| rnb (Vibrio cholerae) | RNase II homolog in a pathogen | Potential drug target |
| rnb (Pseudomonas aeruginosa) | RNase II homolog in a pathogen | Antibiotic resistance and biofilm studies |
| rnb (Staphylococcus aureus) | RNase II homolog in a pathogen | Gram-positive model for RNase II function |
| rnb (Bacillus subtilis) | RNase II homolog in a Gram-positive model | RNA decay studies |
| rnb (Anabaena PCC 7120) | RNase II that interacts with RNase E | Cyanobacterial RNA processing |
| rnb (E. coli) mutant K501Q | Acetylation-mimetic mutant of RNase II | Testing the effect of acetylation on activity |
| rnb (E. coli) mutant K501R | Deacetylation-mimetic mutant of RNase II | Testing the effect of acetylation on activity |
| Exosome complex (eukaryotic) | Eukaryotic counterpart of bacterial 3'-5' exoribonucleases | Comparative and evolutionary studies |
| Rrp44 (yeast) | Eukaryotic exoribonuclease with similar activity | Model for eukaryotic exoribonuclease II-like activity |
| DIS3 (human) | Human exoribonuclease with 3'-5' activity | Cancer and RNA processing studies |
| RNase II inhibitors (small molecules) | Chemical compounds that inhibit RNase II | Antibacterial drug discovery |
How Is exoribonuclease II activity Regulated?
Exoribonuclease II activity is regulated at multiple levels. The most direct mechanism is post-translational modification: reversible acetylation of Lys501 on RNase II reduces its catalytic activity, providing a rapid switch to modulate RNA decay. Additionally, protein-protein interactions, such as binding to RNase E, can influence its recruitment to RNA substrates and its coupling with endonucleolytic cleavage. At the transcriptional level, the expression of rnb may be controlled by growth conditions and stress, although specific transcription factors are not detailed in the cited literature. The activity is also functionally redundant with other 3'-5' exoribonucleases like RNase R and polynucleotide phosphorylase, so cellular RNA turnover reflects the combined action of these enzymes. In eukaryotic systems, the exosome complex, which contains exoribonuclease II-like subunits, is regulated by associated factors and post-translational modifications, but these are outside the scope of the prokaryotic RNase II focus.
exoribonuclease II activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| rnb (M. tuberculosis) | Tuberculosis; bacterial survival | Knockout in M. tuberculosis; infection model |
| rnb (S. typhimurium) | Salmonellosis; virulence | Mouse infection model with rnb deletion |
| DIS3 (human) | Multiple myeloma; cancer | Knockout in myeloma cell lines; RNA-seq |
| Exosome complex (yeast) | RNA processing defects | Yeast knockouts; growth assays |
| rnb (E. coli) | Model for RNA decay | CRISPR knockout; transcriptomics |
Bacterial infections and antibiotic resistance
Exoribonuclease II activity is critical for the survival and virulence of pathogenic bacteria. RNase II homologs in pathogens such as Mycobacterium tuberculosis, Salmonella typhimurium, and Staphylococcus aureus contribute to RNA turnover and stress responses, making them attractive targets for new antibiotics. Inhibiting RNase II could destabilize essential mRNAs and impair bacterial growth, offering a strategy to combat antibiotic-resistant strains.
RNA dysregulation in cancer
While the bacterial RNase II is not directly linked to cancer, its eukaryotic counterparts, such as DIS3, possess 3'-5' exoribonuclease activity and are frequently mutated in multiple myeloma and other cancers. Understanding the fundamental mechanism of exoribonuclease II activity provides a framework for studying how mutations in eukaryotic exoribonucleases contribute to cancer through altered RNA processing and stability.
Neurodegeneration and RNA quality control
Defects in RNA degradation pathways, including 3'-5' exoribonuclease activities, have been implicated in neurodegenerative diseases where RNA quality control is impaired. Although direct evidence for RNase II in neurodegeneration is limited, the conserved nature of exoribonuclease II activity suggests that insights from bacterial models can inform studies of eukaryotic RNA surveillance.
From exoribonuclease II activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of complete loss of RNase II on RNA stability? | CRISPR knockout of rnb in E. coli |
| How does acetylation of Lys501 affect RNase II activity? | Point mutation (K501Q, K501R) knock-in in E. coli |
| Can RNase II be targeted by small-molecule inhibitors? | Overexpression of rnb for purification and inhibitor screening |
| How does RNase II interact with RNase E? | Tagged knock-in (e.g., FLAG-RNase II) for co-immunoprecipitation |
| What is the role of RNase II in bacterial virulence? | Knockout in pathogenic bacteria; infection models |
| How does RNase II processivity compare to RNase R? | Purified enzymes from overexpression strains; in vitro assays |
How to Study the exoribonuclease II activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro degradation assay | Exoribonuclease activity on labeled RNA | Kinetic analysis of RNase II |
| RNA-seq | Global changes in RNA levels | Identifying RNase II targets |
| Co-immunoprecipitation | Protein-protein interactions | Detecting RNase II-RNase E binding |
| Mass spectrometry | Acetylation and other modifications | Mapping Lys501 acetylation |
| CRISPR knockout | Loss-of-function phenotypes | Studying RNase II role in growth |
| Site-directed mutagenesis | Effect of point mutations | Testing K501Q/K501R mutants |
| Enzyme inhibitor screening | Small-molecule inhibition | Antibacterial drug discovery |
| Comparative genomics | Conservation of exoribonuclease II | Evolutionary studies |
In vitro enzymatic assays
Purified RNase II can be incubated with radiolabeled or fluorescently labeled RNA substrates to measure exoribonuclease activity. The release of 5'-phosphomononucleotides can be monitored by thin-layer chromatography or capillary electrophoresis. These assays are used to determine kinetic parameters, processivity, and the effect of mutations or inhibitors.
RNA-seq and transcriptomics
RNA sequencing of cells with altered exoribonuclease II activity (e.g., knockout or point mutants) reveals global changes in mRNA stability and steady-state levels. Comparing wild-type and mutant strains identifies specific RNA substrates and pathways affected by RNase II. This approach is powerful for understanding the physiological role of the enzyme.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry can identify proteins that interact with RNase II, such as RNase E. This helps map the network of RNA processing complexes and understand how exoribonuclease II activity is integrated into cellular machinery.
Structural biology
X-ray crystallography and cryo-electron microscopy can provide atomic-level insights into the catalytic mechanism and substrate binding of RNase II. Structures of wild-type and mutant enzymes, including acetylation mimics, reveal how modifications affect the active site.
How CRISPR Can Be Used to Study GO:0008859 exoribonuclease II activity
Knockout
CRISPR-Cas9 knockout of the rnb gene in bacteria or eukaryotic cells can completely abolish exoribonuclease II activity. This is used to study the physiological consequences, such as changes in mRNA half-life, accumulation of specific transcripts, and effects on growth or virulence. In pathogens, knockout models help validate RNase II as a drug target.
Point Mutation
CRISPR-mediated point mutations can introduce specific amino acid substitutions, such as K501Q (acetylation mimic) or K501R (deacetylation mimic), to dissect the role of post-translational modifications in RNase II activity. These models allow precise testing of how a single residue affects catalytic efficiency and substrate specificity.
Knock-in
Knock-in of tagged versions of RNase II (e.g., FLAG, HA, or GFP) enables visualization, affinity purification, and interaction studies. This approach is valuable for tracking the enzyme's localization and identifying binding partners like RNase E. Knock-in of mutant alleles can also be used to study structure-function relationships.
Overexpression
Overexpression of RNase II, often from a plasmid or integrated promoter, is used to produce large quantities of the enzyme for biochemical and structural studies. It can also be used to titrate activity levels in vivo to examine dose-dependent effects on RNA metabolism.
How EDITGENE Supports exoribonuclease II activity Research
Researchers studying exoribonuclease II activity-related genes often need to determine whether a candidate gene is causally involved in RNA metabolism, stress responses, or bacterial pathogenesis. CRISPR-based models provide a precise way to manipulate these genes and measure the consequences.
Contact EDITGENE today to design your custom CRISPR model for exoribonuclease II activity research.
Frequently Asked Questions About exoribonuclease II activity
What is exoribonuclease II activity?
Exoribonuclease II activity (GO:0008859) is the catalysis of RNA hydrolysis in the 3' to 5' direction, releasing 5'-phosphomononucleotides. It is a molecular function carried out by enzymes such as RNase II.
What genes are involved in exoribonuclease II activity?
The primary gene is rnb, which encodes RNase II in Escherichia coli and many other bacteria. Related genes include rnr (RNase R) and rne (RNase E), which interact with RNase II.
How is exoribonuclease II activity regulated?
It is regulated by post-translational modifications such as reversible acetylation of Lys501, and by protein-protein interactions with RNase E.
What is the difference between RNase II and RNase R?
RNase II is a processive 3'-5' exoribonuclease that stalls at double-stranded RNA, whereas RNase R can degrade structured RNA.
What diseases are associated with exoribonuclease II activity?
In bacteria, it is linked to pathogenicity and antibiotic resistance. In humans, related exoribonucleases like DIS3 are implicated in cancers such as multiple myeloma.
How can I study exoribonuclease II activity in the lab?
Common methods include in vitro degradation assays, RNA-seq, CRISPR knockout, and site-directed mutagenesis.
What is the GO definition of exoribonuclease II activity?
The GO definition is: Catalysis of the reaction: RNA + H2O = 5'-phosphomononucleotides. Cleaves RNA in the 3' to 5' direction.
Can exoribonuclease II be targeted for antibiotics?
Yes, RNase II is essential for RNA turnover in many pathogens and is considered a potential target for new antibacterial drugs.
What are the synonyms for exoribonuclease II activity?
Synonyms include RNase II, ribonuclease II activity, 5'-exoribonuclease activity, Escherichia coli exo-RNase II, ribonuclease Q, and BN ribonuclease activity.
How does acetylation affect RNase II?
Acetylation of Lys501 reduces RNase II catalytic activity, while deacetylation restores it, providing a regulatory switch.
Conclusion
Exoribonuclease II activity (GO:0008859) is a fundamental molecular function that governs RNA stability and turnover in bacteria and beyond. Its mechanism, regulation by acetylation, and interactions with other RNA processing enzymes make it a rich subject for both basic and applied research. The availability of CRISPR tools to knock out, mutate, or tag RNase II enables precise functional studies that can uncover new roles in pathogenesis and RNA biology. As interest in RNA-targeted therapeutics grows, exoribonuclease II activity will remain a key area for discovery.
References
- 1. Song L et al.. 2016. Reversible acetylation on Lys501 regulates the activity of RNase II.. Nucleic Acids Res 44(5):1979-88 PMID: 26847092
- 2. Zhou C et al.. 2020. RNase II binds to RNase E and modulates its endoribonucleolytic activity in the cyanobacterium Anabaena PCC 7120.. Nucleic Acids Res 48(7):3922-3934 PMID: 32055835
- 3. Dos Santos RF et al.. 2018. Major 3'-5' Exoribonucleases in the Metabolism of Coding and Non-coding RNA.. Prog Mol Biol Transl Sci 159:101-155 PMID: 30340785
- 4. Matos RG et al.. 2020. In Vitro Characterization of the Prokaryotic Counterparts of the Exosome Complex.. Methods Mol Biol 2062:47-61 PMID: 31768971
- 5. Arraiano CM et al.. 2010. RNase II: the finer details of the Modus operandi of a molecular killer.. RNA Biol 7(3):276-81 PMID: 20484980
- 6. Andrade JM et al.. 2009. The role of 3'-5' exoribonucleases in RNA degradation.. Prog Mol Biol Transl Sci 85:187-229 PMID: 19215773
- 7. Cheng ZF et al.. 2002. Purification and characterization of the Escherichia coli exoribonuclease RNase R. Comparison with RNase II.. J Biol Chem 277(24):21624-9 PMID: 11948193
- 8. Matos RG et al.. 2024. Identification of Ribonuclease Inhibitors for the Control of Pathogenic Bacteria.. Int J Mol Sci 25(15) PMID: 39125622
